Fusobacterium nucleatum
|
|
|
|
|
Epithelial cells |
Fap2 |
Gal-GalNAc |
|
Tumor binding and enrichment |
Epithelial cells |
|
|
Metalloproteinase collagenase |
Cellular migration and invasive properties |
Epithelial cells |
FadA |
Ecad |
Wnt/β-catenin |
Tumor cell proliferation |
NK cells, T cells |
Fap2 |
TIGIT |
|
Immune evasion |
Epithelial cells |
LPS |
TLR4 |
miR-4802, miR-18a* |
Chemoresistance (autophagy activation) |
Epithelial cells |
LPS |
TLR4 |
Myd88, miR-21 |
Tumor cell proliferation |
|
|
|
|
Recruitment of tumor-infiltrating immune cells (MDSC, TAM, regDC) |
Fusobacterium varium epithelial cells |
|
|
|
Adhesion and invasion, IL-8 and TNF-a production |
Porphyromonas gingivalis
|
|
|
|
|
Epithelial cells |
|
|
Jak1/Akt/Stat3, PI3K/Akt |
Cell survival (antiapoptotic) |
Epithelial cells |
|
|
Cyclin D and E, PI3K |
Cell proliferation |
Epithelial cells |
Gingipain |
β-catenin destruction, complex degradation |
β-catenin |
Cell proliferation |
Epithelial cells |
|
|
|
Immune evasion (B7-H1 and B7-DC upregulation) |
Epithelial cells |
Gingipain |
PAR |
NF-kB, ERK1/2, p38 |
Tumor invasiveness (MMPs expression↑) |
Epithelial cells and others |
|
|
|
Epithelial disruption, proinflammatory cytokine induction, gut dysbiosis |
Epithelial cells and others |
|
|
|
Epithelial disruption, immune activation, gut dysbiosis |
Neutrophils |
|
TLR1-TLR2 |
Myd88 |
Impaired antimicrobial response, Impaired killing activity |
Mø and DC |
Fimbrial proteins (FimA and Mfa1) |
CR3 or DC-SIGN |
MMP and C1q |
Hijack and direct host immune cells (distant tissue destruction) |
Klebsiella pneumoniae, K. aerogenes (K. aeromobilis) epithelial cells |
|
TLR |
IL18 and Myd88 |
Th1 cell generation |
Atopobium parvulum: unknown |
H2S |
|
|
Mitochondrial dysfunction in host with impaired H2S detoxification |
Campylobacter concisus epithelial cells |
|
|
|
Epithelial disruption |
Staphylococcus aureus epithelial cells, T cells |
Enterotoxins |
|
|
Epithelial disruption, immune activation |